Pricing Transparency

In response to continued interest from our members in pharmacy benefit and prescription drug trends, The Council is partnering with McKinsey to conduct a survey on emerging products, solutions, benefit

House and Senate appropriators agreed to a $1.4 trillion spending package that includes major implications for our member firms.

Which bills might pass, which don’t stand a chance, and who’s backing a multi-million dollar ad campaign against benchmark pricing?

Health data systems cannot talk to each other, and it’s a problem.

August 15, 2019 On the eve of the 2018 midterm elections, President Trump unveiled a new part of his “American Patients First” ideology, spurred by the difference in prices Americans

July 18, 2019 President Trump announced the administration’s intention to release an executive order based on a “favored nations” clause. This approach suggests the U.S. would pay for pharmaceuticals at

June 18, 2019 The White House recently released an executive order aimed at requiring insurers, physicians and hospitals to provide patients with more digestible information about the cost of their

June 20, 2019 Our legal team at Steptoe & Johnson tracks healthcare reform bills in the 116th Congress. These documents are updated as of June 14. Federal Healthcare Reform Tracker.

June 20, 2019 In case you missed it, we reported live from The Council’s Employee Benefits Leadership Forum (EBLF). Close to 600 industry leaders convened in Colorado Springs, Colo., to

Surprise Medical Billing Broad bipartisan support from the Trump administration as well as Congress has created momentum around surprise medical billing. Earlier this week, the House Energy and Commerce Committee